Advanced search
Publication Cover
Pediatric Hematology and Oncology Volume 20, 2003 - Issue 3
Submit an article Journal homepage
14
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Thrombophilia in Infancy: Factor V Leiden and MTHFR or Factor II Double Heterozygocity as a Risk Factor

Ariel Koren Pediatric Hematology Unit and Pediatrics Department B, "Ha'Emek" Medical Center, Afula, Israel
,
Carina Levin The Bruce Rappaport School of Medicine, Technion, Haifa, Israel
,
Yaser Hujirat Human Genetics Unit, "Ha'Emek" Medical Center, Afula, Israel
,
Ronit El-Hasid Pediatric Hematology and Oncology Department, Rambam Medical Center, Haifa, Israel
,
Miriam Kutai Pediatric Neurology, "Ha'Emek" Medical Center, Afula, Israel
,
Naomi Lanir Hematology Institute, Rambam Medical Center, Haifa, Israel
,
Stavit Shalev Human Genetics Unit, "Ha'Emek" Medical Center, Afula, Israel
&
Benjamin Brenner Pediatric Hematology Unit and Pediatrics Department B, "Ha'Emek" Medical Center, Afula, Israel
 show all
Pages 219-227 | Published online: 09 Jul 2009

  • Andrew M. Developmental hemostasis: relevance to thromboembolic complications in pediatric patients. Thromb Haemost. 1995;74:415-425.
  • D'Angelo A, Selhub J. Homocysteine and thrombotic disease. Blood. 1997;90:1-11.
  • De Stefano V, Chiusolo P, Paciaroni K, et al. Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients. Blood. 1998;10:3562-3565.
  • McColl MD, Chalmers EA, Thomas A, et al. Factor V Leiden, prothrombin 20210 G? A and the MTHFR C677T mutations in childhood storoke. Thromb Haemost. 1999;81:690-694.
  • Zenz W, Bodo Z, Plotho J, etal. Factor V Leiden and prothrombin gene G 20210 A variant in children with ischemie stroke. Thromb Haemost. 1998;80:763-766.
  • Kenet G, Sadetzki S, Murad H, et al. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke. 2000;31:1283-1288.
  • Nowak-Gottl U, Strater R, Heinecke A, Koch HG, Schuierer G, von Eckardstein A. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood. 1999;94:3678-3682.
  • Heller C, Schobess R, Kumik K, et al. Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors-a multicentre case-control study. Br J Haematol. 2000;111:534-539.
  • Gunther G, Junker R, Strater R, et al. Symptomatic ischemic stroke in full-term neonates: role of acquired and genetic prothrombotic risk factors. Stroke. 2000;31:2437-2441.
  • Dizon-Townson DS, Nelson LM, Jang H, Varner MW, Ward K. The incidence of the factor V Leiden mutation in an obstetric population and its relationship to deep vein thrombosis. Am J Obstet Gynecol. 1997;176:883-886.
  • Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88:3698-3703.
  • Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genet. 1995;10:111-113.
  • Andrew M, David M, Adams M, et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian registry of VTE. Blood. 1994;83:1251-1257.
  • Schmidt B, Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics. 1995;96:939-943.
  • Ehrenforth S, Junker R, Koch HG, et al. Multicentre evaluation of combined prothrombotic defects associated with thrombophilia in childhood: childhood thrombophilia study group. Eur J Pediatr. 1999;158(Suppl 3):S97-S104.
  • Strater R, Vielhaber H, Kassenbohmer R, von-Kries R, Gobel U, Nowak-Gottl U. Genetic risk factors of thrombophilia in ischaemic childhood stroke of cardiac origin: a prospective ESPED survey. Eur J Pediatr. 1999;158(Suppl 3):S122-S125.
  • Junker R, Koch HG, Auberger K, Munchow N, Ehrenforth S, Nowak-Gottl U. Arterioscler Thromi Vase Biol. 1999;19:2568-2572.
  • Vielhaber H, Ehrenforth S, Koch HG, Scharrer I, van der Werf N, Nowak-Gottl U. Cerebral venous sinus thrombosis in infancy and childhood: role of genetic and aquired risk factors of thrombophilia. Eur J Pediatr. 1998;157:555-560.
  • Lawson SE, Butler D, Enayat MS, Williams MD. Congenital thrombophilia and thrombosis: a study in a single center. Arch Dis Child. 1999;81:176-178.
  • Mandel H, Brenner B, Berant M, et al. Coexistence of hereditary homocystinuria and factor V Leiden: effect on thrombosis. N Engl J Med. 1996;334:763-768.
  • Becker S, Heller Ch, Gropp F, Scharrer I, Kreuz W. Thrombophilic disorders in children with cerebral infarction. Lancet. 1998;352:l756-l757.
  • Mercuri E, Cowan F, Gupte G, et al. Prothrombotic disorders and abnormal neurodevelopmental outcome in infants with neonatal cerebral infarction. Pediatrics. 2001;107:1400-1404.
  • Salomon O, Steinberg DM, Zivelin A, et al. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism. Arterioscler Thromb Vase Biol. 1999;19:511-518.
  • Dahlback B. Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism. Blood. 1995;85:607-614.
  • Rodgers GM, Kane WH. Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator. JClin Invest. 1986;77:1909-1916.
  • Rodgers GM, Cohn MT. Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells. Blood. 1990;75:895-901.
  • Nowak-Gottl U, Junker R, Kreuz W, et al. Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors. Blood. 2001;97:858-862.
  • Monagle P, Michelson AD, Bovill E, Andrew M. Antithrombotic therapy in children.Chest. 2001 ;119: 344S-370S.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.